Could a fat and blood injection save your wrist from surgery?

NCT ID NCT03164122

Completed Disease control Sponsor: Assistance Publique Hopitaux De Marseille Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial tested a new injection for wrist osteoarthritis that combines the patient's own fat (microfat) and platelet-rich plasma (PRP). The goal was to see if this mixture is safe and can reduce pain and improve wrist function, potentially delaying the need for surgery. Only 12 people took part, so results are very preliminary.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mixture of the patient's own fat (microfat) and platelet-rich plasma
What this could lead to: If it works, this could offer a less invasive, injection-based treatment to delay or avoid wrist surgery for osteoarthritis.
What could go wrong: This is a very early, small trial with only 12 participants, so results may not apply widely. The treatment may not provide lasting pain relief or cartilage repair.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis osteoarthritis, hand

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OSTEOARTHRITIS

Contacts and locations

Locations

Assisatnce Publique Hopitaux de Marseille

Marseille, 13354, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.